Morphine pretreatment provides histologic protection against ischemia-reperfusion injury in rabbit retina

Retina

Volumn 28, Issue 3, 2008, Pages 511-517

  Riazi Esfahani, Mohammad ^a   Kiumehr, Saman ^a,b   Asadi Amoli, Fahimeh ^a   Lashay, Ali R ^a   Dehpour, Ahmad R ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ischemia; Morphine; Naloxone; Opioid receptor; Pharmacologic preconditioning; Rabbit; Retina

Indexed keywords

MORPHINE SULFATE; NALOXONE; PHOSPHATE BUFFERED SALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; EYE PROTECTION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; RABBIT; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA ISCHEMIA; RETINOPATHY;

ANALGESICS, OPIOID; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS; ISCHEMIC PRECONDITIONING; MALE; MORPHINE; RABBITS; RECEPTORS, OPIOID; REPERFUSION INJURY; RETINA; RETINAL DISEASES; RETINAL VESSELS; VITREOUS BODY;

EID: 40449112638     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31815960c3     Document Type: Article

References (35)

1. Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004;23:91-147.
2. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: recent advances and future perspectives. Vascul Pharmacol 2005;42:211-218.
3. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 2003;35:709-718.
4. Rubaj A, Gustaw K, Zgodzinski W, et al. The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol Biochem Behav 2000;67:65-70.
5. Zhang J, Qian H, Zhao P, et al. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke 2006;37:1094-1099.
6. Roth S, Li B, Rosenbaum PS, et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci 1998;39:777-785.
7. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 2004;100:562-568.
8. Ammon-Treiber S, Stolze D, Schroder H, et al. Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 2005;49:1160-1169.
9. Zhao P, Huang Y, Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 2006;65:945-952.
10. Sakamoto K, Yonoki Y, Kuwagata M, et al. Histological protection against ischemia-reperfusion injury by early ischemic preconditioning in rat retina. Brain Res 2004;1015:154-160.
11. Li B, Roth S. Retinal ischemic preconditioning in the rat: requirement for adenosine and repetitive induction. Invest Ophthalmol Vis Sci 1999;40:1200-1216.
12. Sakamoto K, Kuwagata M, Nakahara T, Ishii K. Late preconditioning in rat retina: involvement of adenosine and ATPsensitive K(+-) channel. Eur J Pharmacol 2001;418:89-93.
13. Peart JN, Gross GJ. Cross-talk between adenosine and opioid receptors. Drug News Perspect 2005;18:237-242.
14. Peart JN, Gross GJ. Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol 2003;285:H81-H89.
15. Bagnoli P, Dal Monte M, Casini G. Expression of neuropeptides and their receptors in the developing retina of mammals. Histol Histopathol 2003;18:1219-1242.
16. Lam TT, Takahashi K, Tso MO. The effects of naloxone on retinal ischemia in rats. J Ocul Pharmacol 1994;10:481-492.
17. Vidal-Sanz M, Lafuente M, Sobrado-Calvo P, et al. Death and neuroprotection of retinal ganglion cells after different types of injury. Neurotox Res 2000;2:215-227.
18. Morrison VL, Koh HJ, Cheng L, et al. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 2006;26:339-344.
19. Molina PE. Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness. J Intern Med 2006;259:138-154.
20. Harman AM, Moore S. Number of neurons in the retinal ganglion cell layer of the quokka wallaby do not change throughout life. Anat Rec 1999;256:78-83.
21. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001;89:123-137.
22. Schulz R, Cohen MV, Behrends M, et al. Signal transduction of ischemic preconditioning. Cardiovasc Res 2001;52:181-198.
23. Li B, Yang C, Rosenbaum DM, Roth S. Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp Eye Res 2000;70:775-765.
24. Ettaiche M, Heurteaux C, Blondeau N, et al. ATP-sensitive potassium channels (K(ATP)) in retina: a key role for delayed ischemic tolerance. Brain Res 2001;890:118-129.
25. Roth S, Dreixler JC, Shaikh AR, et al. Mitochondrial potassium ATP channels and retinal ischemic preconditioning. Invest Ophthalmol Vis Sci 2006;47:2114-2124.
26. Roth S. Endogenous neuroprotection in the retina. Brain Res Bull 2004;62:461-466.
27. Yamauchi T, Kashii S, Yasuyoshi H, et al. Mitochondrial ATP-sensitive potassium channel: a novel site for neuroprotection. Invest Ophthalmol Vis Sci 2003;44:2750-2756.
28. O'Rourke B. Evidence for mitochondrial K+- channels and their role in cardioprotection. Circ Res 2004;94:420-432.
29. Bonne C, Muller A, Villain M. Free radicals in retinal ischemia. Gen Pharmacol 1998;30:275-280.
30. Liu D, Lu C, Wan R, et al. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab 2002;22:431-443.
31. Balasubramanian S, Ramakrishnan S, Charboneau R, et al. Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol 2001;33:2179-2187.
32. Roy S, Balasubramanian S, Wang J, et al. Morphine inhibits VEGF expression in myocardial ischemia. Surgery 2003;134:336-344.
33. Gradert TL, Baze WB, Satterfield WC, et al. Safety of chronic intrathecal morphine infusion in a sheep model. Anesthesiology 2003;99:188-198.
34. Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology 2003;99:174-187.
35. Bito LZ. Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. Exp Eye Res 1984;39:807-829.